IMMUTRAIN is an Innovative Training Network which received 3,6 Mio. € from the EU Marie Curie Actions for four years (2015-2019). It brings together experts in the fields of monoclonal antibodies, dendritic cells, T-cells and immunomodulatory nucleic acids with a considerable industrial involvement.
The network comprises nine academic research groups and five industrial partners in a total of nine European countries. IMMUTRAIN creates actively synergies between those sectors by forming and promoting young researchers to match the challenges of immunotherapies. Particular focus is placed on combinatorial therapies and on the new emerging field of bispecific antibodies used to target both the tumor and the patient´s immune system. 15 Ph. D. students (Early Stage Researchers, ESR) reinforced by the project leaders investigate innovative therapeutic strategies and provide the rationale for future clinical trials.
Throughout their projects, ESR learn to integrate academic and industrial aspects and sharpen their experimental and complementary skills in a well-designed and diversified training program.
This project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement N° 641549.
Company Details
- Founded
- -
- Address
- Lindwurmstraße 2a, Division Of Clinical Pharmacology,germany
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Munich, Bavaria
- Competitors
- T-RAFIC - Tracking and controlling therapeutic immune cells in cancer, I-DireCT, Marie Curie Innovative Training Network (ITN), Network for Optimizing Adoptive T cell Therapy (T-OP), PG Consulting Pharma, Institut Français de Micro-immunothérapie IFMi, Les RIIP : Les Rencontres en Immunologie et Immunothérapie Pratiques, ENDOSCAPE, LEBAO_MHH, CytoArm｜BsAb Armed-T Therapy Platform Revolutionizing T Cell Cancer Treatment, BCThubs.
Immutrain - Training Network For The Immunotherapy Of Cancer Questions
Immutrain - Training Network For The Immunotherapy Of Cancer's website is http://www.klinikum.uni-muenchen.de/Immutrain/de/index.html
Immutrain - Training Network For The Immunotherapy Of Cancer's LinkedIn profile is https://de.linkedin.com/company/immutrain
Immutrain - Training Network For The Immunotherapy Of Cancer's industry is
Pharmaceutical Manufacturing
Immutrain - Training Network For The Immunotherapy Of Cancer's top competitors are
T-Rafic - Tracking And Controlling Therapeutic Immune Cells In Cancer,
I-Direct, Marie Curie Innovative Training Network (Itn),
Network For Optimizing Adoptive T Cell Therapy (T-Op),
Pg Consulting Pharma,
Institut Français De Micro-Immunothérapie Ifmi,
Les Riip : Les Rencontres En Immunologie Et Immunothérapie Pratiques,
Endoscape,
Lebao_mhh,
Cytoarm｜bsab Armed-T Therapy Platform Revolutionizing T Cell Cancer Treatment,
Bcthubs.
Immutrain - Training Network For The Immunotherapy Of Cancer's categories are Pharmaceutical Manufacturing
Immutrain - Training Network For The Immunotherapy Of Cancer's founding year is 2015
